In Vivo Method to Monitor Changes in HER2 Expression Using Near-Infrared Fluorescence Imaging
Human epidermal growth factor receptor type 2 (HER2) is a well-known biomarker that is overexpressed in many breast carcinomas. HER2 expression level is an important factor to optimize the therapeutic strategy and monitor the treatment. We used albumin binding domain–fused HER2-specific Affibody mol...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2012-05-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2011.00038 |